Статті в журналах з теми "HIV-1 proteasi"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-50 статей у журналах для дослідження на тему "HIV-1 proteasi".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Pan, Bowen, Sumei Li, Junwei Xiao, Xin Yang, Shouxia Xie, Ying Zhou, Jian Yang, and Ying Wei. "Dual Inhibition of HIV-1 and Cathepsin L Proteases by Sarcandra glabra." Molecules 27, no. 17 (August 29, 2022): 5552. http://dx.doi.org/10.3390/molecules27175552.
Повний текст джерелаPark, Jung-Ho, Yoshihiro Yamaguchi, and Masayori Inouye. "Intramolecular Regulation of the Sequence-Specific mRNA Interferase Activity of MazF Fused to a MazE Fragment with a Linker Cleavable by Specific Proteases." Applied and Environmental Microbiology 78, no. 11 (March 23, 2012): 3794–99. http://dx.doi.org/10.1128/aem.00364-12.
Повний текст джерелаCapel, Elena, Glòria Martrus, Mariona Parera, Bonaventura Clotet, and Miguel Angel Martínez. "Evolution of the human immunodeficiency virus type 1 protease: effects on viral replication capacity and protease robustness." Journal of General Virology 93, no. 12 (December 1, 2012): 2625–34. http://dx.doi.org/10.1099/vir.0.045492-0.
Повний текст джерелаMartínez, Miguel-Angel, Marta Cabana, Mariona Parera, Arantxa Gutierrez, José A. Esté, and Bonaventura Clotet. "A Bacteriophage Lambda-Based Genetic Screen for Characterization of the Activity and Phenotype of the Human Immunodeficiency Virus Type 1 Protease." Antimicrobial Agents and Chemotherapy 44, no. 5 (May 1, 2000): 1132–39. http://dx.doi.org/10.1128/aac.44.5.1132-1139.2000.
Повний текст джерелаMcPHEE, Fiona, Patricia S. CALDERA, Guy W. BEMIS, Antony F. McDONAGH, Irwin D. KUNTZ, and Charles S. CRAIK. "Bile pigments as HIV-1 protease inhibitors and their effects on HIV-1 viral maturation and infectivity in vitro." Biochemical Journal 320, no. 2 (December 1, 1996): 681–86. http://dx.doi.org/10.1042/bj3200681.
Повний текст джерелаRaugi, Dana N., Robert A. Smith, and Geoffrey S. Gottlieb. "Four Amino Acid Changes in HIV-2 Protease Confer Class-Wide Sensitivity to Protease Inhibitors." Journal of Virology 90, no. 2 (November 11, 2015): 1062–69. http://dx.doi.org/10.1128/jvi.01772-15.
Повний текст джерелаÁlvarez, Enrique, Luis Menéndez-Arias, and Luis Carrasco. "The Eukaryotic Translation Initiation Factor 4GI Is Cleaved by Different Retroviral Proteases." Journal of Virology 77, no. 23 (December 1, 2003): 12392–400. http://dx.doi.org/10.1128/jvi.77.23.12392-12400.2003.
Повний текст джерелаÁlvarez, Enrique, Alfredo Castelló, Luis Menéndez-Arias, and Luis Carrasco. "HIV protease cleaves poly(A)-binding protein." Biochemical Journal 396, no. 2 (May 15, 2006): 219–26. http://dx.doi.org/10.1042/bj20060108.
Повний текст джерелаDAVIS, David A., Fonda M. NEWCOMB, Jackob MOSKOVITZ, Paul T. WINGFIELD, Stephen J. STAHL, Joshua KAUFMAN, Henry M. FALES, Rodney L. LEVINE, and Robert YARCHOAN. "HIV-2 protease is inactivated after oxidation at the dimer interface and activity can be partly restored with methionine sulphoxide reductase." Biochemical Journal 346, no. 2 (February 22, 2000): 305–11. http://dx.doi.org/10.1042/bj3460305.
Повний текст джерелаSohraby, Farzin, and Hassan Aryapour. "Comparative analysis of the unbinding pathways of antiviral drug Indinavir from HIV and HTLV1 proteases by supervised molecular dynamics simulation." PLOS ONE 16, no. 9 (September 27, 2021): e0257916. http://dx.doi.org/10.1371/journal.pone.0257916.
Повний текст джерелаSavarino, Andrea, Roberto Cauda, and Antonio Cassone. "Aspartic Proteases ofPlasmodium falciparumas the Target of HIV‐1 Protease Inhibitors." Journal of Infectious Diseases 191, no. 8 (April 15, 2005): 1381–82. http://dx.doi.org/10.1086/428781.
Повний текст джерелаVisnegarwala, Fehmida, Daniel M. Musher, and A. C. White. "HIV-1 Protease Inhibitors May Interfere with the Ubiquitous Intracellular Proteases." Annals of Internal Medicine 135, no. 9 (November 6, 2001): 840. http://dx.doi.org/10.7326/0003-4819-135-9-200111060-00017.
Повний текст джерелаYanchunas, Joseph, David R. Langley, Li Tao, Ronald E. Rose, Jacques Friborg, Richard J. Colonno, and Michael L. Doyle. "Molecular Basis for Increased Susceptibility of Isolates with Atazanavir Resistance-Conferring Substitution I50L to Other Protease Inhibitors." Antimicrobial Agents and Chemotherapy 49, no. 9 (September 2005): 3825–32. http://dx.doi.org/10.1128/aac.49.9.3825-3832.2005.
Повний текст джерелаEron, Joseph J. "HIV-1 Protease Inhibitors." Clinical Infectious Diseases 30, Supplement_2 (June 1, 2000): S160—S170. http://dx.doi.org/10.1086/313853.
Повний текст джерела&NA;. "HIV-1 protease inhibitors." Inpharma Weekly &NA;, no. 840 (June 1992): 13. http://dx.doi.org/10.2165/00128413-199208400-00018.
Повний текст джерелаEdwards, Paul. "HIV-1 protease inhibitors." Drug Discovery Today 6, no. 8 (April 2001): 437–39. http://dx.doi.org/10.1016/s1359-6446(01)01736-6.
Повний текст джерелаDeeks, Steven G. "HIV-1 Protease Inhibitors." JAMA 277, no. 2 (January 8, 1997): 145. http://dx.doi.org/10.1001/jama.1997.03540260059037.
Повний текст джерелаParikh, Sunil, Jiri Gut, Eva Istvan, Daniel E. Goldberg, Diane V. Havlir, and Philip J. Rosenthal. "Antimalarial Activity of Human Immunodeficiency Virus Type 1 Protease Inhibitors." Antimicrobial Agents and Chemotherapy 49, no. 7 (July 2005): 2983–85. http://dx.doi.org/10.1128/aac.49.7.2983-2985.2005.
Повний текст джерелаBagossi, Péter, Tamás Sperka, Anita Fehér, János Kádas, Gábor Zahuczky, Gabriella Miklóssy, Péter Boross, and József Tözsér. "Amino Acid Preferences for a Critical Substrate Binding Subsite of Retroviral Proteases in Type 1 Cleavage Sites." Journal of Virology 79, no. 7 (April 1, 2005): 4213–18. http://dx.doi.org/10.1128/jvi.79.7.4213-4218.2005.
Повний текст джерелаLin, Ying-Chuan, Zachary Beck, Taekyu Lee, Van-Duc Le, Garrett M. Morris, Arthur J. Olson, Chi-Huey Wong, and John H. Elder. "Alteration of Substrate and Inhibitor Specificity of Feline Immunodeficiency Virus Protease." Journal of Virology 74, no. 10 (May 15, 2000): 4710–20. http://dx.doi.org/10.1128/jvi.74.10.4710-4720.2000.
Повний текст джерелаASANTE-APPIAH, Ernest, and William W. C. CHAN. "Synergistic binding of inhibitors to the protease from HIV type 1." Biochemical Journal 315, no. 1 (April 1, 1996): 113–17. http://dx.doi.org/10.1042/bj3150113.
Повний текст джерелаPettit, Steven C., Sergei Gulnik, Lori Everitt, and Andrew H. Kaplan. "The Dimer Interfaces of Protease and Extra-Protease Domains Influence the Activation of Protease and the Specificity of GagPol Cleavage." Journal of Virology 77, no. 1 (January 1, 2003): 366–74. http://dx.doi.org/10.1128/jvi.77.1.366-374.2003.
Повний текст джерелаDavis, David A., Haydar Bulut, Prabha Shrestha, Hiroaki Mitsuya, and Robert Yarchoan. "Regulation of Retroviral and SARS-CoV-2 Protease Dimerization and Activity through Reversible Oxidation." Antioxidants 11, no. 10 (October 18, 2022): 2054. http://dx.doi.org/10.3390/antiox11102054.
Повний текст джерелаDekhtyar, Tatyana, Teresa I. Ng, Liangjun Lu, Sherie Masse, David A. DeGoey, William J. Flosi, David J. Grampovnik, Larry L. Klein, Dale J. Kempf, and Akhteruzzaman Molla. "Characterization of a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, A-790742." Antimicrobial Agents and Chemotherapy 52, no. 4 (January 22, 2008): 1337–44. http://dx.doi.org/10.1128/aac.01132-07.
Повний текст джерелаMeek, Thomas D. "Inhibitors of HIV-1 Protease." Journal of Enzyme Inhibition 6, no. 1 (January 1992): 65–98. http://dx.doi.org/10.3109/14756369209041357.
Повний текст джерелаPapa, Anna, Evagelia Papadimitriou, Androniki Papoutsi, and Antonis Antoniadis. "M36I, protease gene, HIV-1." AIDS 17, no. 12 (August 2003): 1858–59. http://dx.doi.org/10.1097/00002030-200308150-00019.
Повний текст джерелаBaures, Paul W. "Heterocyclic HIV-1 Protease Inhibitors." Organic Letters 1, no. 2 (July 1999): 249–52. http://dx.doi.org/10.1021/ol990586y.
Повний текст джерелаLouis, John M., Rieko Ishima, Issa Nesheiwat, Lewis K. Pannell, Shannon M. Lynch, Dennis A. Torchia, and Angela M. Gronenborn. "Revisiting Monomeric HIV-1 Protease." Journal of Biological Chemistry 278, no. 8 (December 4, 2002): 6085–92. http://dx.doi.org/10.1074/jbc.m209726200.
Повний текст джерелаIkezoe, Takayuki, Yasuko Hisatake, Tamotsu Takeuchi, Yuji Ohtsuki, Yang Yang, Jonathan W. Said, Hirokuni Taguchi, and H. Phillip Koeffler. "HIV-1 Protease Inhibitor, Ritonavir." Cancer Research 64, no. 20 (October 15, 2004): 7426–31. http://dx.doi.org/10.1158/0008-5472.can-03-2677.
Повний текст джерелаBonini, Carlo, Lucia Chiummiento, Margherita De Bonis, Nadia Di Blasio, Maria Funicello, Paolo Lupattelli, Rocco Pandolfo, Francesco Tramutola, and Federico Berti. "Synthesis of New Thienyl Ring Containing HIV-1 Protease Inhibitors: Promising Preliminary Pharmacological Evaluation against Recombinant HIV-1 Proteases§." Journal of Medicinal Chemistry 53, no. 4 (February 25, 2010): 1451–57. http://dx.doi.org/10.1021/jm900846f.
Повний текст джерелаPrabu-Jeyabalan, Moses, Ellen A. Nalivaika, Nancy M. King, and Celia A. Schiffer. "Structural Basis for Coevolution of a Human Immunodeficiency Virus Type 1 Nucleocapsid-p1 Cleavage Site with a V82A Drug-Resistant Mutation in Viral Protease." Journal of Virology 78, no. 22 (November 15, 2004): 12446–54. http://dx.doi.org/10.1128/jvi.78.22.12446-12454.2004.
Повний текст джерелаKádas, János, Péter Boross, Irene T. Weber, Péter Bagossi, Krisztina Matúz, and József Tözsér. "C-terminal residues of mature human T-lymphotropic virus type 1 protease are critical for dimerization and catalytic activity." Biochemical Journal 416, no. 3 (November 26, 2008): 357–64. http://dx.doi.org/10.1042/bj20071132.
Повний текст джерелаPan, Bo Wen, Jun Wei Xiao, Su Mei Li, Xin Yang, Xia Zhou, Qing Wen Sun, Mei Chen, et al. "Inhibitors of HIV-1 and Cathepsin L Proteases Identified from the Insect Gall of Hypericum kouytchense." Pharmaceuticals 15, no. 12 (November 30, 2022): 1499. http://dx.doi.org/10.3390/ph15121499.
Повний текст джерелаWlodawer, A., M. Miller, M. Jaskolski, B. Sathyanarayana, E. Baldwin, I. Weber, L. Selk, L. Clawson, J. Schneider, and S. Kent. "Conserved folding in retroviral proteases: crystal structure of a synthetic HIV-1 protease." Science 245, no. 4918 (August 2, 1989): 616–21. http://dx.doi.org/10.1126/science.2548279.
Повний текст джерелаBossi, Philippe, Mireille Mouroux, Anne Yvon, François Bricaire, Henri Agut, Jean-Marie Huraux, Christine Katlama, and Vincent Calvez. "Polymorphism of the Human Immunodeficiency Virus Type 1 (HIV-1) Protease Gene and Response of HIV-1-Infected Patients to a Protease Inhibitor." Journal of Clinical Microbiology 37, no. 9 (1999): 2910–12. http://dx.doi.org/10.1128/jcm.37.9.2910-2912.1999.
Повний текст джерелаHu, Qing-Xiu, Guo-Qing Zhang, Rui-Ying Zhang, Dan-Dan Hu, He-Xiang Wang, and Tzi Bun Ng. "A Novel Aspartic Protease with HIV-1 Reverse Transcriptase Inhibitory Activity from Fresh Fruiting Bodies of the Wild MushroomXylaria hypoxylon." Journal of Biomedicine and Biotechnology 2012 (2012): 1–8. http://dx.doi.org/10.1155/2012/728975.
Повний текст джерелаMammano, Fabrizio, Caroline Petit, and François Clavel. "Resistance-Associated Loss of Viral Fitness in Human Immunodeficiency Virus Type 1: Phenotypic Analysis of Protease andgag Coevolution in Protease Inhibitor-Treated Patients." Journal of Virology 72, no. 9 (September 1, 1998): 7632–37. http://dx.doi.org/10.1128/jvi.72.9.7632-7637.1998.
Повний текст джерелаCordelier, Pierre, та David S. Strayer. "Mechanisms of α1-antitrypsin inhibition of cellular serine proteases and HIV-1 protease that are essential for HIV-1 morphogenesis". Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 1638, № 3 (липень 2003): 197–207. http://dx.doi.org/10.1016/s0925-4439(03)00084-x.
Повний текст джерелаRhee, Soo-Yon, Jonathan Taylor, W. Jeffrey Fessel, David Kaufman, William Towner, Paolo Troia, Peter Ruane, et al. "HIV-1 Protease Mutations and Protease Inhibitor Cross-Resistance." Antimicrobial Agents and Chemotherapy 54, no. 10 (July 26, 2010): 4253–61. http://dx.doi.org/10.1128/aac.00574-10.
Повний текст джерелаHernandez-Sanchez, Pedro G., Sandra E. Guerra-Palomares, J. Rafael Arguello, Daniel E. Noyola, and Christian A. Garcia-Sepulveda. "Mexican HIV-1 Protease Sequence Diversity." AIDS Research and Human Retroviruses 36, no. 2 (February 1, 2020): 161–66. http://dx.doi.org/10.1089/aid.2019.0201.
Повний текст джерелаBeck, Z., G. Morris, and J. Elder. "Defining HIV-1 Protease Substrate Selectivity." Current Drug Target -Infectious Disorders 2, no. 1 (March 1, 2002): 37–50. http://dx.doi.org/10.2174/1568005024605837.
Повний текст джерелаIshima, Rieko, Rodolfo Ghirlando, József Tözsér, Angela M. Gronenborn, Dennis A. Torchia, and John M. Louis. "Folded Monomer of HIV-1 Protease." Journal of Biological Chemistry 276, no. 52 (October 11, 2001): 49110–16. http://dx.doi.org/10.1074/jbc.m108136200.
Повний текст джерелаCatamancio, Simona La Seta, and Stefano Rusconi. "HIV-1 protease inhibitors in development." Expert Opinion on Investigational Drugs 11, no. 3 (March 2002): 387–95. http://dx.doi.org/10.1517/13543784.11.3.387.
Повний текст джерелаMargolin, Nara, Albert Dee, Mei Lai, and Chris J. Vlahos. "Purification of Recombinant HIV-1 Protease." Preparative Biochemistry 21, no. 2-3 (June 1991): 163–73. http://dx.doi.org/10.1080/10826069108018011.
Повний текст джерелаHeal, J. W., S. A. Wells, E. Jimenez-Roldan, R. F. Freedman, and R. A. Römer. "Rigidity analysis of HIV-1 protease." Journal of Physics: Conference Series 286 (March 1, 2011): 012006. http://dx.doi.org/10.1088/1742-6596/286/1/012006.
Повний текст джерелаVacca, J. P., P. M. D. Fitzgerald, M. K. Holloway, R. W. Hungate, K. E. Starbuck, L. J. Chen, P. L. Darke, P. S. Anderson, and J. R. Huff. "Conformationally constrained HIV-1 protease inhibitors." Bioorganic & Medicinal Chemistry Letters 4, no. 3 (February 1994): 499–504. http://dx.doi.org/10.1016/0960-894x(94)80025-1.
Повний текст джерелаVacca, Joseph P., and Jon H. Condra. "Clinically effective HIV-1 protease inhibitors." Drug Discovery Today 2, no. 7 (July 1997): 261–72. http://dx.doi.org/10.1016/s1359-6446(97)01053-2.
Повний текст джерелаBlanco, Raquel, Luis Carrasco, and Iván Ventoso. "Cell Killing by HIV-1 Protease." Journal of Biological Chemistry 278, no. 2 (October 4, 2002): 1086–93. http://dx.doi.org/10.1074/jbc.m205636200.
Повний текст джерелаRozzelle, James E., Deborah S. Dauber, Stephen Todd, Robert Kelley, and Charles S. Craik. "Macromolecular Inhibitors of HIV-1 Protease." Journal of Biological Chemistry 275, no. 10 (March 10, 2000): 7080–86. http://dx.doi.org/10.1074/jbc.275.10.7080.
Повний текст джерелаYao, Shao, Reena Zutshi, and Jean Chmielewski. "Endothiopeptide inhibitors of HIV-1 protease." Bioorganic & Medicinal Chemistry Letters 8, no. 6 (March 1998): 699–704. http://dx.doi.org/10.1016/s0960-894x(98)00100-0.
Повний текст джерела